Hiroyoshi Mori

Showing 1-3 of 3 articles

Author Hiroyuki Jinnouchi

Coronary interventions

Thromboresistance and functional healing in the COBRA PzF stent versus competitor DES: implications for dual antiplatelet therapy

Jinnouchi H, Mori H, Cheng Q, Kutyna M, Torii S, Sakamoto A, Guo L, Acampado E, Gupta A, Kolodgie F, Virmani R, Finn A

July 19, 2019 | 10.4244/EIJ-D-18-00740

Author Sho Torii

Stents and scaffolds

Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents

Torii S, Cheng Q, Mori H, Lipinski M, Acampado E, Perkins L, Hossainy S, Pacetti S, Kolodgie F, Virmani R, Finn A

March 20, 2019 | 10.4244/EIJ-D-17-00728

Author Oscar D. Sanchez

Coronary interventions

Pathological aspects of bioresorbable stent implantation

Sanchez O, Yahagi K, Byrne R, Mori H, Zarpak R, Wittchow E, Foin N, Virmani R, Joner M

May 19, 2015 | 10.4244/EIJV11SVA39

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke